作者
- Antman, E.M. (54)
- Braunwald, E. (117)
- Cannon, C.P. (33)
- Gibson, C.M. (35)
- Giugliano, R.P. (29)
- McCabe, C.H. (49)
- Morrow, D.A. (39)
- Murphy, S.A. (31)
- Sabatine, M.S. (20)
- de Lemos, J.A. (21)
|
總筆數:117
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Relation between systemic anticoagulation as determined by activatedpartial thromboplastin time and heparin measurements and in-hospitalclinical events in unstable angina and non-Q wave myocardial infarction |
Becker, R.C.;Cannon, C.P.;Tracy, R.P.;Thompson, B.;Bovill, E.G.;Desvigne-Nickens, P.;Randall, A.M.Y.;Knatternud, G.;Braunwald, E.;Thrombolysis in Myocardial Ischemia III B Investigators; |
American Heart Journal |
1996-03-01 |
查看 |
| Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A |
Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
1997-10-01 |
查看 |
| Myoglobin, creatine kinase MB, and cardiac troponin-I to assessreperfusion after thrombolysis for acute myocardial infarction: Resultsfrom TIMI 10A |
Tanasijevic, M.J.;Cannon, C.P.;Wybenga, D.R.;Fischer, G.A.;Grudzien, C.;Gibson, C.;Winkelman, J.W.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
1997-10-01 |
查看 |
| Rationale and clinical evidence for the use of GP IIb/IIIa inhibitorsin acute coronary syndromes |
Braunwald, E.;Maseri, A.;Armstrong, P.W.;Califf, R.M.;Gibler, W.;Hamm, C.W.;Simoons, M.L.;Van de Werf, F.; |
American Heart Journal |
1998-04-01 |
查看 |
| Introduction |
Braunwald, E.; |
American Heart Journal |
1998-06-01 |
查看 |
| Introduction |
Braunwald, E.; |
American Heart Journal |
1998-06-01 |
查看 |
| Introduction |
Braunwald, E.; |
American Heart Journal |
1998-06-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| Safety assessment of single-bolus administration of TNKtissue-plasminogen activator in acute myocardial infarction: The ASSENT-1trial |
For the ASSENT-1 investigators*;Van de Werf, F.;Cannon, C.P.;Luyten, A.;Houbracken, K.;McCabe, C.H.;Berioli, S.;Bluhmki, E.;Sarelin, H.;Wang-Clow, F.;Fox, N.L.;Braunwald, E.; |
American Heart Journal |
1999-05-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor(RPR 109891) in patients with recent acute coronary syndromes: Results ofthe TIMI 15A and 15B trials |
Giugliano, R.P.;McCabe, C.H.;Sequeira, R.F.;Frey, M.J.;Henry, T.D.;Piana, R.N.;Tamby, J.-F.;Jensen, B.K.;Nicolas, S.B.;Jennings, L.K.;Wise, R.J.;Braunwald, E.;for the TIMI 15A and 15B Investigators^*; |
American Heart Journal |
2000-07-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with a bedsidemyoglobin assay and the 12-lead electrocardiogram |
de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.;for the InTIME-II investigators; |
American Heart Journal |
2000-09-01 |
查看 |
| Very early risk stratification after thrombolytic therapy with abedside myoglobin assay and the 12-lead electrocardiogram |
for the InTIME-II investigators;de Lemos, J.A.;Antman, E.M.;Giugliano, R.P.;Morrow, D.A.;McCabe, C.H.;Charlesworth, A.;Schroder, R.;Braunwald, E.; |
American Heart Journal |
2000-09-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogen activator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.M.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Determination of a weight-adjusted dose of TNK-tissue plasminogenactivator |
Wang-Clow, F.;Fox, N.L.;Cannon, C.P.;Gibson, C.;Berioli, S.;Bluhmki, E.;Danays, T.;Braunwald, E.;Van de Werf, F.;Stump, D.C.; |
American Heart Journal |
2001-01-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Abciximab and early adjunctive percutaneous coronary intervention areassociated with improved ST-segment resolution after thrombolysis:Observations from the TIMI 14 Trial |
de Lemos, J.A.;Gibson, C.M.;Antman, E.M.;Murphy, S.A.;Morrow, D.A.;Schuhwerk, K.C.;Schweiger, M.;Coussement, P.;Van de Werf, F.;Braunwald, E.;for the TIMI 14 Investigators; |
American Heart Journal |
2001-04-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.;for the Thrombolysis in Myocardial Infarction (TIMI) Investigators; |
American Heart Journal |
2001-05-01 |
查看 |
| Lower-dose heparin with fibrinolysis is associated with lower rates ofintracranial hemorrhage |
for the Thrombolysis in Myocardial Infarction (TIMI) Investigators;Giugliano, R.P.;McCabe, C.H.;Antman, E.M.;Cannon, C.P.;de Werf, F.V.;Wilcox, R.G.;Braunwald, E.; |
American Heart Journal |
2001-05-01 |
查看 |
| Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy |
Srinivas, V.S.;Cannon, C.P.;Gibson, C.M.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; |
American Heart Journal |
2001-07-01 |
查看 |
| Myoglobin levels at 12 hours identify patients at low risk for 30-daymortality after thrombolysis in acute myocardial infarction: A Thrombolysisin Myocardial Infarction 10B substudy |
Srinivas, V.S.;Cannon, C.P.;Gibson, C.;Antman, E.M.;Greenberg, M.A.;Tanasijevic, M.J.;Murphy, S.;de Lemos, J.A.;Sokol, S.;Braunwald, E.;Mueller, H.S.; |
American Heart Journal |
2001-07-01 |
查看 |
| The A-to-Z Trial: Methods and rationale for a single trial investigatingcombined use of low-molecular-weight heparin with the glycoprotein IIb/IIIainhibitor tirofiban and defining the efficacy of early aggressivesimvastatin therapy |
Blazing, M.A.;de Lemos, J.A.;Dyke, C.K.;Califf, R.M.;Bilheimer, D.;Braunwald, E.; |
American Heart Journal |
2001-08-01 |
查看 |
| The A-to-Z Trial: Methods and rationale for a single trialinvestigating combined use of low-molecular-weight heparin with theglycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy ofearly aggressive simvastatin therapy |
Blazing, M.A.;de Lemos, J.A.;Dyke, C.K.;Califf, R.M.;Bilheimer, D.;Braunwald, E.; |
American Heart Journal |
2001-08-01 |
查看 |
| The continuation of the Prevention of Events With Angiotensin-ConvertingEnzyme Inhibition (PEACE) Trial |
Pfeffer, M.A.;Domanski, M.;Verter, J.;Dunlap, M.;Flaker, G.C.;Gersh, B.;Hsia, J.;Goldberg, A.D.;Limacher, M.C.;Maggioni, A.P.;Rosenberg, Y.;Rouleau, J.-L.;Warnica, J.W.;Wasserman, A.G.;Braunwald, E.;for the PEACE Investigators; |
American Heart Journal |
2001-09-01 |
查看 |
| The continuation of the Prevention of Events WithAngiotensin-Converting Enzyme Inhibition (PEACE) Trial |
for the PEACE Investigators;Pfeffer, M.A.;Domanski, M.;Verter, J.;Dunlap, M.;Flaker, G.C.;Gersh, B.;Hsia, J.;Goldberg, A.;Limacher, M.C.;Maggioni, A.P.;Rosenberg, Y.;Rouleau, J.L.;Warnica, J.;Wasserman, A.G.;Braunwald, E.; |
American Heart Journal |
2001-09-01 |
查看 |
| The continuation of the Prevention of Events WithAngiotensin-Converting Enzyme Inhibition (PEACE) Trial |
Pfeffer, M.A.;Domanski, M.;Verter, J.;Dunlap, M.;Flaker, G.C.;Gersh, B.;Hsia, J.;Goldberg, A.;Limacher, M.C.;Maggioni, A.P.;Rosenberg, Y.;Rouleau, J.L.;Warnica, J.;Wasserman, A.G.;Braunwald, E.;for the PEACE Investigators; |
American Heart Journal |
2001-09-01 |
查看 |
| A second look at bivalirudin |
Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2001-12-01 |
查看 |
| A second look at bivalirudin |
Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2001-12-01 |
查看 |
| A second look at bivalirudin |
Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2001-12-01 |
查看 |
| Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial |
Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Bivalirudin as a replacement for unfractionated heparin in unstableangina/non-ST-elevation myocardial infarction: Observations from the TIMI 8trial |
Antman, E.M.;McCabe, C.H.;Braunwald, E.;for the TIMI 8 Investigators; |
American Heart Journal |
2002-02-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Identification of patients at high risk for death and cardiac ischemicevents after hospital discharge |
Sabatine, M.S.;McCabe, C.H.;Morrow, D.A.;Giugliano, R.P.;de Lemos, J.A.;Cohen, M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-06-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.M.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Impact of diabetes mellitus on epicardial and microvascular flow afterfibrinolytic therapy |
Angeja, B.G.;de Lemos, J.;Murphy, S.A.;Marble, S.J.;Antman, E.M.;Cannon, C.P.;Braunwald, E.;Gibson, C.;TIMI Study Group; |
American Heart Journal |
2002-10-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method for identifyingpatients with a patent infarction-related artery after fibrinolyticadministration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Minimal ST-segment deviation: A simple, noninvasive method foridentifying patients with a patent infarction-related artery afterfibrinolytic administration |
Cooper, H.A.;de Lemos, J.A.;Morrow, D.A.;Sabatine, M.S.;Murphy, S.A.;McCabe, C.H.;Gibson, C.M.;Antman, E.M.;Braunwald, E.; |
American Heart Journal |
2002-11-01 |
查看 |
| Direct comparison of characteristics, treatment, and outcomes of patientsenrolled versus patients not enrolled in a clinical trial at centersparticipating in the TIMI 9 Trial and TIMI 9 Registry |
Bahit, M.C.;Cannon, C.P.;Antman, E.M.;Murphy, S.A.;Gibson, C.M.;McCabe, C.H.;Braunwald, E.; |
American Heart Journal |
2003-01-01 |
查看 |
| Prior peripheral arterial disease and cerebrovascular disease areindependent predictors of adverse outcome in patients with acute coronarysyndromes: Are we doing enough? Results from the Orbofiban in Patients withUnstable Coronary Syndromes-Thrombolysis In Myocardial Infarction(OPUS-TIMI) 16 study |
Cotter, G.;Cannon, C.P.;McCabe, C.H.;Michowitz, Y.;Kaluski, E.;Charlesworth, A.;Milo, O.;Bentley, J.;Blatt, A.;Krakover, R.;Zimlichman, R.;Reisin, L.;Marmor, A.;Lewis, B.;Vered, Z.;Caspi, A.;Braunwald, E.;OPUS-TIMI 16 Investigators; |
American Heart Journal |
2003-04-01 |
查看 |
| Angiographic and clinical characteristics associated with the developmentof q-wave and non-q-wave myocardial infarction in the thrombolysis inmyocardial infarction (timi) 14 trial |
Murphy, S.A.;Dauterman, K.;de Lemos, J.A.;Kermgard, S.;Antman, E.M.;Braunwald, E.;Gibson, C.M.;Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Angiographic and clinical characteristics associated with thedevelopment of q-wave and non-q-wave myocardial infarction in thethrombolysis in myocardial infarction (timi) 14 trial |
Murphy, S.A.;Dauterman, K.;de Lemos, J.A.;Kermgard, S.;Antman, E.M.;Braunwald, E.;Gibson, C.;Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators; |
American Heart Journal |
2003-07-01 |
查看 |
| Association of the timing of ST-segment resolution with TIMI myocardialperfusion grade in acute myocardial infarction |
Gibson, C.M.;Karha, J.;Giugliano, R.P.;Roe, M.T.;Murphy, S.A.;Harrington, R.A.;Green, C.L.;Schweiger, M.J.;Miklin, J.S.;Baran, K.W.;Palmeri, S.;Braunwald, E.;Krucoff, M.W.;INTEGRITI Study Group; |
American Heart Journal |
2004-05-01 |
查看 |
| Association of the timing of ST-segment resolution with TIMI myocardialperfusion grade in acute myocardial infarction |
Gibson, C.M.;Karha, J.;Giugliano, R.P.;Roe, M.T.;Murphy, S.A.;Harrington, R.A.;Green, C.L.;Schweiger, M.J.;Miklin, J.S.;Baran, K.W.;Palmeri, S.;Braunwald, E.;Krucoff, M.W.;INTEGRITI Study Group; |
American Heart Journal |
2004-05-01 |
查看 |
|
|
|
